| Name | Title | Contact Details |
|---|
Evergreen Research Corporation has performed contract product development with an emphasis on medical devices since 1988. Evergreen Research offers a complete range of development services from product definition and feasibility studies through detailed design to pilot-run and low-volume production.Their experience and resourceful staff, seasoned program management, and knowledge of regulations ensure customer satisfaction and compliance with regulatory requirements. Evergreen Research, Inc. also known as ERI, has developed advanced electromechanical and software-based products providing a complete range of development services, such as product requirements definition, project planning, risk management, comprehensive design expertise (electrical, mechanical, software and industrial), design documentation, verification and validation, clinical studies, regulatory approvals, production quality planning and much more. Evergreen Research Advantages include highly skilled electrical, mechanical, and software engineers, on-site regulatory and quality expertise, manufacturing capability to build prototypes and marketed products such as Therapeutic Devices, Diagnostic Systems, Medical Software and Medical Imaging products.
UroMed is a Suwanee, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Brown and Toland Physicians Services Organization is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.
Variant Pharmaceuticals is an orphan drug company leveraging advanced proprietary technologies to develop best-in-class drugs for patients with rare diseases.